Tolvaptan use is limited to less than 30 days due to the potential for liver toxicity and it should not be used in patients with liver or kidney disease Hypertonic saline infusion should be reserved for patients with severe, symptomatic hyponatremia and should be used cautiously because too-rapid correction risks complication, s such as the osmotic demyelination syndrome.